Myo-inositol in the treatment of hormonal, metabolic and reproductive features of polycystic ovary syndrome (review of the literature
Pechlivanov, B.
Akusherstvo i Ginekologiia 49(3): 37-39
2010
ISSN/ISBN: 0324-0959 PMID: 20734654 Document Number: 647921
Document emailed within 1 workday
Related Documents
Uras, R.; Orrù, M.; Pani, F.; Marotto, M.F.; Pilloni, M.; Guerriero, S.; Etzi, R.; Zedda, P.; Sorge, R.; Lello, S.; Melis, G.B.; Paoletti, A.M. 2010: Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome Contraception 82(2): 131-138Indhavivadhana, S.; Wongwananuruk, T.; Rattanachaiyanont, M.; Techatraisak, K.; Leerasiri, P.; Tanmahasamut, P.; Popijan, M. 2010: Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women Journal of the Medical Association of Thailand 93(6): 653-660
Seow, K.-M.; Juan, C.-C.; Hwang, J.-L.; Ho, L.-T. 2008: Laparoscopic surgery in polycystic ovary syndrome: reproductive and metabolic effects Seminars in Reproductive Medicine 26(1): 101-110
Kachalina, T.S.; Dobrotina, A.F. 1988: Reproductive function following the surgical treatment of polycystic ovary syndrome Akusherstvo i Ginekologiia 5: 62-63
Pekhlivanov, B.; Mitkov, M.; Kavŭrdzhikova, S. 2006: Clinical, hormonal and biochemical changes after treatment with metformin and weight reduction in women with polycystic ovary syndrome Akusherstvo i Ginekologiia 45(6): 29-35
Le Donne, M.; Alibrandi, A.; Giarrusso, R.; Lo Monaco, I.; Muraca, U. 2012: Diet, metformin and inositol in overweight and obese women with polycystic ovary syndrome: effects on body composition Minerva Ginecologica 64(1): 23-29
Minozzi, M.; Costantino, D.; Guaraldi, C.; Unfer, V. 2011: The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 27(11): 920-924
Beltadze, K.; Barbakadze, L. 2015: Ovarian reserve in the women of late reproductive age after conservative treatment of polycystic ovary syndrome in adolescence Georgian Medical News 238: 27-31
Pantasri, T.; Vutyavanich, T.; Sreshthaputra, O.; Srisupundit, K.; Piromlertamorn, W. 2010: Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome Journal of the Medical Association of Thailand 93(4): 406-412
Kamrul-Hasan, A.B.; Aalpona, F.Z. 2019: Association of Vitamin D Status with Metabolic Syndrome and its Components in Polycystic Ovary Syndrome Mymensingh medical journal: MMJ 28(3): 547-552
Cheung, L.P.; Ma, R.C.W.; Lam, P.M.; Lok, I.H.; Haines, C.J.; So, W.Y.; Tong, P.C.Y.; Cockram, C.S.; Chow, C.C.; Goggins, W.B. 2008: Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome Human Reproduction 23(6): 1431-1438
Singh, K.B.; Mahajan, D.K.; Wortsman, J. 1994: Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome Journal of Reproductive Medicine 39(10): 805-808
Soares, G.M.; Vieira, C.S.; de Paula Martins, W.; Dos Reis, R.M.; de Sá, M.F.S.; Ferriani, R.A. 2009: Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome International Journal of Clinical Practice 63(1): 160-169
Ehrmann, D.A.; Schwarz, P.E.H.; Hara, M.; Tang, X.; Horikawa, Y.; Imperial, J.; Bell, G.I.; Cox, N.J. 2002: Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 87(4): 1669-1673
Sengos, C.; Andreakos, C.; Iatrakis, G. 2000: Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome Clinical and Experimental Obstetrics and Gynecology 27(1): 35-38
Barber, T.M.; McCarthy, M.I.; Franks, S.; Wass, J.A.H. 2007: Metabolic syndrome in polycystic ovary syndrome Endokrynologia Polska 58(1): 34-41
Ehrmann, D.A.; Tang, X.; Yoshiuchi, I.; Cox, N.J.; Bell, G.I. 2002: Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome Journal of Clinical Endocrinology and Metabolism 87(9): 4297-4300
Wongwananuruk, T.; Indhavivadhana, S.; Rattanachaiyanont, M.; Techatraisak, K.; Leerasiri, P.; Tanmahasamut, P.; Angsuwathana, S.; Dangrat, C. 2010: Characteristics of 250 reproductive-aged polycystic ovary syndrome Thai women at Siriraj Hospital Journal of the Medical Association of Thailand 93(4): 399-405
Mes-Krowinkel, M.G.; Louwers, Y.V.; Mulders, A.G.M.G.J.; de Jong, F.H.; Fauser, B.C.J.M.; Laven, J.S.E. 2014: Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients Fertility and Sterility 101(6): 1757-65.E1
Banaszewska, B.; Spaczyński, R.Z.; Ozegowska, K.; Pawelczyk, L. 2011: The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome Ginekologia Polska 82(6): 430-435